1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. UNITED STATES AI in Scientific Discovery Market By Application Area
5.1. Introduction
5.2. Drug Discovery & Pharmaceuticals
5.3. Materials Science & Engineering
5.4. Genomics & Molecular Biology
5.5. Climate & Environmental Science
5.6. Physics, Quantum & Chemistry Research
5.7. Astronomy & Space Science
5.8. Agricultural & Food Science
6. UNITED STATES AI in Scientific Discovery Market By Deployment
6.1. Introduction
6.2. Cloud-Based
6.3. On-Premise
6.4. Hybrid Deployment
7. UNITED STATES AI in Scientific Discovery Market By End-User
7.1. Introduction
7.2. Pharmaceutical & Biotechnology Companies
7.3. Chemical & Materials Manufacturers
7.4. Academic & Research Institutions
7.5. Government Research Agencies & Laboratories
7.6. Space & Defense Organizations
7.7. Technology & AI Solution Providers
8. COMPETITIVE ENVIRONMENT AND ANALYSIS
8.1. Major Players and Strategy Analysis
8.2. Market Share Analysis
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Competitive Dashboard
9. COMPANY PROFILES
9.1. Insilico Medicine
9.2. NVIDIA
9.3. Recursion Pharmaceuticals
9.4. Schrödinger, Inc.
9.5. Atomwise Inc.
9.6. Valo Health
9.7. Verseon
9.8. Collaborative Drug Discovery (CDD)
9.9. Dotmatics
9.10. Genesis Therapeutics
10. APPENDIX
10.1. Currency
10.2. Assumptions
10.3. Base and Forecast Years Timeline
10.4. Key benefits for the stakeholders
10.5. Research Methodology
10.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES